Jason Zemansky is a Vice President in Equity Research covering Small & Medium Cap Biopharma. Previously, he was a vice president at Barclays after starting his career in equity research at SVB Leerink. He earned his PhD in Molecular and Cell Biology from the University of California, Berkeley, and his AB degree in Molecular Biology from Princeton. He is based in New York.